In this study, cut-off values for high-sensitivity cardiac troponin I (hs-cTnI), creatine phosphokinase-MB (CK-MB), CK, and myoglobin (MYO) equivalent to ~49% ULN and a cut-off value of N-terminal pro-brain natriuretic peptide (NT-proBNP) equivalent of ~18.9% ULN were established for the prediction of adverse outcomes in COVID-19 patients, and patients with higher hs-cTnI, CK-MB, CK, MYO, and (NT-pro) BNP levels than the cut-off values were correlated with increased risk of death (39). The gene discussed is NPPB; the disease is COVID-19.